S. Mori, H. Furukawa, Y. Kawaguchi, T. Suda, S. Tasaka
{"title":"间质性肺疾病的最新进展","authors":"S. Mori, H. Furukawa, Y. Kawaguchi, T. Suda, S. Tasaka","doi":"10.4137/CCRPM.S40867","DOIUrl":null,"url":null,"abstract":"Articles should focus on ILD and may include the following topics: New advances in ILD § § Clinical approaches to patients with ILD § § End-points to measure improvement in clinical studies § § This supplement is intended to focus on interstitial lung disease. New treatment advances, clinical approaches to patients with interstitial lung disease (ILD) and end-points to measure improvement in clinical studies are included within the supplement’s scope.","PeriodicalId":44269,"journal":{"name":"Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine","volume":"9 1","pages":"173 - 177"},"PeriodicalIF":1.0000,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Current Developments in Interstitial Lung Disease\",\"authors\":\"S. Mori, H. Furukawa, Y. Kawaguchi, T. Suda, S. Tasaka\",\"doi\":\"10.4137/CCRPM.S40867\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Articles should focus on ILD and may include the following topics: New advances in ILD § § Clinical approaches to patients with ILD § § End-points to measure improvement in clinical studies § § This supplement is intended to focus on interstitial lung disease. New treatment advances, clinical approaches to patients with interstitial lung disease (ILD) and end-points to measure improvement in clinical studies are included within the supplement’s scope.\",\"PeriodicalId\":44269,\"journal\":{\"name\":\"Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine\",\"volume\":\"9 1\",\"pages\":\"173 - 177\"},\"PeriodicalIF\":1.0000,\"publicationDate\":\"2015-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4137/CCRPM.S40867\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4137/CCRPM.S40867","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
Articles should focus on ILD and may include the following topics: New advances in ILD § § Clinical approaches to patients with ILD § § End-points to measure improvement in clinical studies § § This supplement is intended to focus on interstitial lung disease. New treatment advances, clinical approaches to patients with interstitial lung disease (ILD) and end-points to measure improvement in clinical studies are included within the supplement’s scope.